Oak Longevity vs Regenics: Pricing, Clinician Type, and Features
Oak Longevity vs Regenics is a direct comparison of two telehealth options for compounded GLP-1 weight-loss medications. Early verdict: Oak Longevity emphasizes lower flat prices and no subscription, while Regenics emphasizes first-month promotions and nurse-practitioner oversight with a peptide add-on.
See Oak Longevity pricing and details
How they differ at a glance
Both platforms offer compounded semaglutide and tirzepatide and note that compounded medications are not FDA-approved finished products. The most distinctive differences supported by the source are: pricing structure and renewals, clinician model, ancillary offerings, requirement for video visits, and promotional detail or lack thereof. Below we compare these differences directly.
1. Pricing structure and renewal terms
Oak Longevity lists semaglutide from $133/month and tirzepatide from $199/month as one flat price that covers all dosages and states no subscriptions or membership fees. Oak bills monthly on a non-recurring basis and three-month prescriptions are billed upfront; no refunds are available after physician approval and once medication has shipped. Regenics advertises semaglutide at $139 for the first month and tirzepatide at $189 for the first month, with promotional first-month pricing that renews at higher rates (semaglutide renews at $199/month and tirzepatide at $279/month unless otherwise stated). The source notes Regenics’ promotional pricing applies to the first month only.
View Regenics first-month offers
2. Clinician oversight and care model
Oak Longevity states board-certified physicians in your state review every case and that the clinical review is asynchronous with no video call required. Regenics describes licensed nurse practitioners who review intake before prescription and positions care as nurse-practitioner-led. Both require a licensed clinician to determine treatment appropriateness.
3. Additional services and focus areas
Oak includes free health coaching and free shipping with tracking as part of its offering and highlights same-day approval for qualifying patients. Regenics includes free shipping and advertises a Sermorelin peptide therapy add-on for recovery, energy, and muscle support, and notes its pharmacy network is LegitScript certified.
4. Compounding, regulatory, and eligibility notes
Both sources explicitly state compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness, or quality. Oak specifies patients with BMI below 20 do not qualify for GLP-1 treatment and Oak notes not for patients under 18, pregnant, or nursing. Regenics also notes treatment is available only when a licensed clinician determines it is medically appropriate.
Side-by-side comparison table
| Criteria | Oak Longevity | Regenics |
|---|---|---|
| Starting semaglutide price | $133/mo (one flat price) | $139 first month (renews $199/mo) |
| Starting tirzepatide price | $199/mo (one flat price) | $189 first month (renews $279/mo) |
| Subscription / billing | No subscription; billed monthly non-recurring; 3-month prescriptions billed upfront | Promotional first month; renewal prices higher unless stated |
| Clinician type | Board-certified physicians review each case | Licensed nurse practitioners oversee prescriptions |
| Additional services | Free health coaching included | Sermorelin peptide therapy available |
| Compounding and regulatory note | Compounded medications are not FDA-approved finished products | Compounded medications are not FDA-approved finished products |
| Shipping | Free shipping with tracking | Free shipping; medication compounded in the USA |
Practical implications of the differences
If cost predictability and a flat-price model without recurring subscriptions are priorities, Oak Longevity’s semaglutide from $133/month and tirzepatide from $199/month with one price for all dosages and free coaching is the supported option. If a lower initial outlay for the first month and access to a peptide add-on matter, Regenics’ $139 first month for semaglutide and $189 first month for tirzepatide with nurse-practitioner-led care and a Sermorelin option is the supported option, keeping in mind renewals move to higher monthly prices.
Start with Oak Longevity pricing
Safety, eligibility, and process differences
Both platforms require a licensed clinician to determine medical appropriateness and both note compounded medications are not FDA-approved as finished products. Oak states no video call is required and that clinician review is asynchronous, while Regenics notes licensed nurse practitioners review intake before anything is prescribed. Oak also lists eligibility limits such as patients with BMI below 20 not qualifying for GLP-1 treatment and excludes minors, pregnant, or nursing patients.
Compare Oak Longevity eligibility
Bottom line: Oak Longevity vs Regenics
Oak Longevity vs Regenics centers on whether you prefer predictable flat pricing and included coaching with physician review and no video call, or promotional entry pricing with nurse-practitioner oversight and an optional peptide offering. Both use compounded medications and require clinician approval.
Choose Oak Longevity if you want lower flat starting prices, no subscription model, free health coaching, board-certified physician review, and asynchronous clinical review. Choose Regenics if you value lower first-month promotional pricing, nurse-practitioner-led telehealth care, and access to Sermorelin peptide therapy.